What does commercial auto liability — year 4 mean?

This metric represents the total earned premiums or revenue generated from the commercial auto liability insurance segment during the fourth year of the reporting period. It reflects the company's market exposure and underwriting activity within the commercial vehicle insurance sector. Monitoring this figure helps investors assess the scale and growth trajectory of the business unit over time.

King Pharmaceuticals KG Commercial Auto Liability — Year 4

Other product segments

General Liability

15.9%—

European Hospital Liability

13.7%—

All other lines

4.7%—

International

-0.3%—

Similar metrics at other companies

ORICommercial Automobile — Year 4

11.7%+0.2pp

KMPRCommercial Automobile Insurance—Liability — Year 4

79.2%-3.0pp

CNACommercial Auto — Year 4

15.2%+0.6pp

UFCSCommercial other liability — Year 4

16.5%+0.8pp

UFCSCommercial automobile — Year 4

11.8%-0.6pp

KMPRCommercial Automobile Insurance—Liability — Year 5

91.6%+1.1pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's commercial auto liability — year 4.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's commercial auto liability — year 4?: King Pharmaceuticals (KG) reported commercial auto liability — year 4 of 18.2% in Q4 2025.
What does commercial auto liability — year 4 mean?: This metric represents the total earned premiums or revenue generated from the commercial auto liability insurance segment during the fourth year of the reporting period. It reflects the company's market exposure and underwriting activity within the commercial vehicle insurance sector. Monitoring this figure helps investors assess the scale and growth trajectory of the business unit over time.